Abstract
Background
The characteristics of patients receiving chronic hemodialysis in the United States has continuously changed over the past three decades. Today the patients are older, and the incidence of diabetic nephropathy has markedly increased. Hypotension during hemodialysis is the most common and bothersome complication of chronic hemodialysis. The demographics of those patients who experience hypotension during dialysis has not been previously identified.
Methods
The change in systolic pressure during hemodialysis was reviewed for ten consecutive hemodialysis treatments in 134 patients in a single hospital-based unit. For the past four years, those patients who have had symptoms during their hypotensive episodes associated with hemodialysis have been under continuous therapy with midodrine.
Results
In the present study, the overall incidence of patients experiencing decreases of, at least, 40 mmHg systolic pressure, in over 50% of their treatments, is 63%. The incidence of patients having symptoms from hypotension during hemodialysis is 25%. Analysis of the dialysis population shows that the age of the patients is a primary factor leading to hypotension. Diabetic nephropathy is identified as a second risk factor for hypotension. However, the incidence in the asymptomatic group versus the symptomatic group was not statistically significant. In the group of patients (25%) who have hypotension during hemodialysis with clinical symptoms, all had hypertension requiring therapy prior to initiating hemodialysis. Hypertension may be a predisposing factor to the development of hypotension. Females tended to have more hypotension during dialysis than males.
Conclusions
As a result of the increasing age of patients receiving hemodialysis and the increasing incidence of diabetic nephropathy, hypotension will become an even greater problem in the future.
Similar content being viewed by others
References
Sellers AL, Gral T. Morbidity and mortality in patients undergoing maintenance hemodialysis. In: Massry SG, Sellers AL, editors. Clinical Aspects of Uremia and Dialysis, chap 21, Springfield, Illinois, Charles C. Thomas 1976; 616–638.
Carrell WR. The status of haemodilaysis. In: Anderton JL, Parsons FM, Jones DE, editors. Living With Renal Failure, chap 2, Baltimore, Maryland, University Park Press 1978; 21–34.
Kaufman AM, Polaschegg HD, Levin NW. Common clinical problems during hemodialysis. In: Nissenson AR, Fine RN, editors. Dialysis Therapy (ed 2), chap 9, Philadelphia, Pennsylvania, Hanley & Belfus, Inc 1993; 109–113.
Bregman H, Daugirdas JT, Ing TS. Complications during hemodialysis. In: Daugirdas JT, Ing TS, editors. Handbook of Dialysis (ed 2), chap 9, United States of America, Little, Brown and Company 1994; 149–157.
III. Incidence and Causes of Treated ESRD, Supplement to Am J Kidney Diseases 1993: 22 (4), Suppl 2, October: 30–37.
Jankovic J, Hiner BC, Brown DC, Rubin M. Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine. Am J of Med 1993; 95: July 38–47.
Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J of Med 1995; 99, December: 604–610.
Flynn JJ, Mitchell MC, Caruso FS, McElligott MA. Midodrine treatment of patients with hemodialysis hypotension. Clinical Nephrology 1996; 45, April: 261–267.
Blowey DL, Balfe JW, Gupta I, Gajaria MM, Koren G. Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension. Am J Kidney Diseeases 1996; 28 (1), July: 132–136.
Prevalence of ESRD therapy. Am J Kidney Diseases 1995; 26 (4), Supp 2 (October); S30–S38.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flynn, J.J. Factors contributing to hypotension during hemodialysis. Geriatric Nephrol Urol 6, 99–104 (1996). https://doi.org/10.1007/BF00451113
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00451113